PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.710
+0.100 (2.77%)
At close: Oct 28, 2025, 4:00 PM EDT
3.700
-0.010 (-0.27%)
After-hours: Oct 28, 2025, 4:49 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $58.08 million as of October 28, 2025. Its market cap has increased by 146.00% in one year.
Market Cap
58.08M
Enterprise Value
37.14M
1-Year Change
146.00%
Ranking
Category
Stock Price
$3.71
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $58.08M, a decrease of -29.55%. That is a compound annual growth rate of -6.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 58.08M | 180.80% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |